The recent class I recall of a Penumbra cardiac device used in mechanical thrombectomy procedures provides a case study for the shortcomings of the current 510(k) medical device clearance process and ...

Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.

PenumbraPEN on Sunday unveiled results of a "landmark" study that showed its Lightning Flash device is superior to blood thinners, alone, in patients with pulmonary embolism. The results could reshape ...

A deep dive into the rocky history of the JET 7 reperfusion catheter with Xtra Flex Technology, published this week in JAMA Internal Medicine, is aiming to renew discussions on medical device safety.

Key Points Interested in Globus Medical, Inc.? Here are five stocks we like better. Globus Medical continues to grow revenue ...

BOSTON, Mass. - July 27, 2016 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...

Short seller Quintessential Capital Management raised concerns over the safety of Penumbra Inc.’s Jet 7 catheter for stroke victims in a new report Tuesday. Shares of the company tumbled in early ...

Jan 15 (Reuters) - Boston Scientific ‌agreed to buy medtech firm Penumbra in ‌a $14.5 billion deal on Thursday, its second‑largest takeover ever, as it looks to re-enter the neurovascular market and ...

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot ...